1. Home
  2. TGS vs PTCT Comparison

TGS vs PTCT Comparison

Compare TGS & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Transportadora de Gas del Sur SA TGS

TGS

Transportadora de Gas del Sur SA TGS

HOLD

Current Price

$29.65

Market Cap

4.7B

Sector

Utilities

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$66.98

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGS
PTCT
Founded
1992
1998
Country
Argentina
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
5.5B
IPO Year
2002
2006

Fundamental Metrics

Financial Performance
Metric
TGS
PTCT
Price
$29.65
$66.98
Analyst Decision
Strong Buy
Buy
Analyst Count
1
17
Target Price
$40.00
$79.41
AVG Volume (30 Days)
197.7K
1.0M
Earning Date
01-01-0001
05-12-2026
Dividend Yield
3.13%
N/A
EPS Growth
N/A
264.48
EPS
N/A
7.78
Revenue
N/A
$264,734,000.00
Revenue This Year
$50.92
N/A
Revenue Next Year
N/A
$22.81
P/E Ratio
$17.56
$8.72
Revenue Growth
N/A
36.19
52 Week Low
$19.74
$35.95
52 Week High
$34.10
$87.50

Technical Indicators

Market Signals
Indicator
TGS
PTCT
Relative Strength Index (RSI) 47.30 29.79
Support Level $27.94 $57.74
Resistance Level $32.56 $68.44
Average True Range (ATR) 1.50 2.79
MACD -0.01 -0.28
Stochastic Oscillator 49.56 19.53

Price Performance

Historical Comparison
TGS
PTCT

About TGS Transportadora de Gas del Sur SA TGS

Transportadora de Gas del Sur SA is a transporters of natural gas in Latin America. The company's operating segments include Natural Gas Transportation, Midstream, Telecommunications, Production and Commercialization Liquids, Other Services, and Telecommunications. It generates maximum revenue from the Production and Commercialization of the Liquids segment. Geographically, it derives the majority of its revenue from Argentina.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: